ATE421317T1 - Pharmazeutische zubereitungen zur oralen anwendung enthaltend pradofloxacin-beladene ionentauscherharze sowie strukturviskose gelbildner als verdicker - Google Patents
Pharmazeutische zubereitungen zur oralen anwendung enthaltend pradofloxacin-beladene ionentauscherharze sowie strukturviskose gelbildner als verdickerInfo
- Publication number
- ATE421317T1 ATE421317T1 AT03755931T AT03755931T ATE421317T1 AT E421317 T1 ATE421317 T1 AT E421317T1 AT 03755931 T AT03755931 T AT 03755931T AT 03755931 T AT03755931 T AT 03755931T AT E421317 T1 ATE421317 T1 AT E421317T1
- Authority
- AT
- Austria
- Prior art keywords
- thickeners
- structurally
- ion exchange
- pharmaceutical preparations
- exchange resins
- Prior art date
Links
- 229920000297 Rayon Polymers 0.000 title 1
- 239000003456 ion exchange resin Substances 0.000 title 1
- 229920003303 ion-exchange polymer Polymers 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000002562 thickening agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10224086A DE10224086A1 (de) | 2002-05-31 | 2002-05-31 | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421317T1 true ATE421317T1 (de) | 2009-02-15 |
Family
ID=29432468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03755931T ATE421317T1 (de) | 2002-05-31 | 2003-05-19 | Pharmazeutische zubereitungen zur oralen anwendung enthaltend pradofloxacin-beladene ionentauscherharze sowie strukturviskose gelbildner als verdicker |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8545829B2 (enExample) |
| EP (1) | EP1513500B1 (enExample) |
| JP (2) | JP5350574B2 (enExample) |
| KR (3) | KR20120123607A (enExample) |
| CN (1) | CN1671361B (enExample) |
| AR (2) | AR039861A1 (enExample) |
| AT (1) | ATE421317T1 (enExample) |
| AU (1) | AU2003242545B2 (enExample) |
| BR (2) | BR0311511A (enExample) |
| CA (1) | CA2487648C (enExample) |
| CR (1) | CR7598A (enExample) |
| DE (2) | DE10224086A1 (enExample) |
| DK (1) | DK1513500T3 (enExample) |
| ES (1) | ES2319115T3 (enExample) |
| HR (1) | HRP20041219B1 (enExample) |
| IL (2) | IL165322A0 (enExample) |
| MX (1) | MXPA04011820A (enExample) |
| MY (1) | MY140953A (enExample) |
| NO (1) | NO333939B1 (enExample) |
| PL (1) | PL207269B1 (enExample) |
| PT (1) | PT1513500E (enExample) |
| RU (1) | RU2380091C2 (enExample) |
| SI (1) | SI1513500T1 (enExample) |
| TW (1) | TWI333422B (enExample) |
| UA (1) | UA84270C2 (enExample) |
| WO (1) | WO2003101422A2 (enExample) |
| ZA (1) | ZA200409616B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
| WO2006061700A2 (en) * | 2004-12-06 | 2006-06-15 | Themis Laboratories Private Limited | Rapid disintegrating taste masked compositions and a process for its preparations |
| DE102005025900A1 (de) * | 2005-06-06 | 2006-12-07 | Basf Ag | Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch |
| US20080051332A1 (en) * | 2005-11-18 | 2008-02-28 | Nastech Pharmaceutical Company Inc. | Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| CN100360131C (zh) * | 2006-01-24 | 2008-01-09 | 新昌国邦化学工业有限公司 | 一种掩味恩诺沙星的生产方法 |
| US20070248564A1 (en) * | 2006-04-25 | 2007-10-25 | Roxane Laboratories, Inc. | Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia |
| EP2066302A2 (en) * | 2006-09-26 | 2009-06-10 | Taro Pharmaceuticals North America, Inc. | Stabilizing compositions for antibiotics and methods of use |
| DE102006049520A1 (de) | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
| US20080118570A1 (en) * | 2006-11-20 | 2008-05-22 | Zhi Liu | Polymer coated drug-ion exchange resins and methods |
| US20090247575A1 (en) * | 2008-03-26 | 2009-10-01 | Taro Pharmaceuticals North America, Inc. | Stabilizing lipid compositions for oral pharmaceutical agents |
| PT2544532T (pt) | 2010-03-12 | 2017-06-02 | Monsanto Technology Llc | Composições de gel agroquímicas |
| BR112012029461A2 (pt) * | 2010-05-19 | 2017-03-01 | Astellas Pharma Inc | composição farmacêutica contendo solifenacina |
| CN103957894A (zh) | 2011-10-19 | 2014-07-30 | R.P.谢勒技术有限公司 | 两相药物递送系统 |
| FR2998305B1 (fr) * | 2012-11-22 | 2015-02-20 | Henkel Ag & Co Kgaa | Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire |
| KR101697095B1 (ko) * | 2015-09-30 | 2017-01-18 | 주식회사 포스코 | 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크 |
| MX2020011280A (es) | 2018-04-25 | 2020-11-13 | Bayer Animal Health Gmbh | Proceso para la hidrolisis de esteres carboxilicos de quinolona. |
| CN114249749B (zh) * | 2022-01-08 | 2024-03-22 | 天象生物药业邢台有限责任公司 | 一种马波沙星甲酸盐的转化方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US614622A (en) * | 1898-11-22 | Machine for making billets | ||
| JPS60204713A (ja) * | 1984-03-30 | 1985-10-16 | Zenyaku Kogyo Kk | 水性懸濁組成物 |
| GB8618847D0 (en) * | 1986-08-01 | 1986-09-10 | Smith Kline French Lab | Pharmaceutical formulations |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| US5338732A (en) * | 1991-06-18 | 1994-08-16 | Bristol-Myers Squibb Company | Megestrol acetate formulation |
| SK43694A3 (en) * | 1991-10-28 | 1995-01-12 | Procter & Gamble | Drinking system thickener/emulsifier |
| JP3207494B2 (ja) * | 1992-04-02 | 2001-09-10 | ロート製薬株式会社 | 水性懸濁製剤 |
| DE4319649A1 (de) * | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
| HU228036B1 (en) * | 1996-02-23 | 2012-08-28 | Bayer Animal Health Gmbh | Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives, process producing them and medicaments thereof |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| JP2003504416A (ja) * | 1999-07-14 | 2003-02-04 | シェーリング−プラウ・リミテッド | イオン交換樹脂を使用する経口キノロン液状製剤の味覚マスキング |
| GB9930058D0 (en) * | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
| GB0020089D0 (en) * | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
| DE10134719A1 (de) * | 2001-07-17 | 2003-02-06 | Bayer Ag | Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze |
| US7001667B2 (en) * | 2002-07-17 | 2006-02-21 | Ppg Industries Ohio, Inc. | Alkyd-based free radical wood coating compositions |
-
2002
- 2002-05-31 DE DE10224086A patent/DE10224086A1/de not_active Withdrawn
-
2003
- 2003-05-19 US US10/516,344 patent/US8545829B2/en not_active Expired - Fee Related
- 2003-05-19 AU AU2003242545A patent/AU2003242545B2/en not_active Expired
- 2003-05-19 EP EP03755931A patent/EP1513500B1/de not_active Expired - Lifetime
- 2003-05-19 SI SI200331534T patent/SI1513500T1/sl unknown
- 2003-05-19 PT PT03755931T patent/PT1513500E/pt unknown
- 2003-05-19 CA CA2487648A patent/CA2487648C/en not_active Expired - Lifetime
- 2003-05-19 HR HRP20041219AA patent/HRP20041219B1/hr not_active IP Right Cessation
- 2003-05-19 KR KR1020127026888A patent/KR20120123607A/ko not_active Ceased
- 2003-05-19 RU RU2004139022/15A patent/RU2380091C2/ru active
- 2003-05-19 PL PL373456A patent/PL207269B1/pl unknown
- 2003-05-19 KR KR10-2004-7019371A patent/KR20050010015A/ko not_active Ceased
- 2003-05-19 BR BR0311511-9A patent/BR0311511A/pt active IP Right Grant
- 2003-05-19 IL IL16532203A patent/IL165322A0/xx unknown
- 2003-05-19 UA UA20041210942A patent/UA84270C2/ru unknown
- 2003-05-19 ES ES03755931T patent/ES2319115T3/es not_active Expired - Lifetime
- 2003-05-19 MX MXPA04011820A patent/MXPA04011820A/es active IP Right Grant
- 2003-05-19 DK DK03755931T patent/DK1513500T3/da active
- 2003-05-19 DE DE50311123T patent/DE50311123D1/de not_active Expired - Lifetime
- 2003-05-19 BR BRPI0311511-9A patent/BRPI0311511B1/pt unknown
- 2003-05-19 JP JP2004508780A patent/JP5350574B2/ja not_active Expired - Lifetime
- 2003-05-19 AT AT03755931T patent/ATE421317T1/de active
- 2003-05-19 KR KR1020117031524A patent/KR101258373B1/ko not_active Expired - Lifetime
- 2003-05-19 CN CN038182106A patent/CN1671361B/zh not_active Expired - Lifetime
- 2003-05-19 WO PCT/EP2003/005228 patent/WO2003101422A2/de not_active Ceased
- 2003-05-28 AR ARP030101867A patent/AR039861A1/es not_active Application Discontinuation
- 2003-05-29 MY MYPI20031984A patent/MY140953A/en unknown
- 2003-05-30 TW TW092114643A patent/TWI333422B/zh not_active IP Right Cessation
-
2004
- 2004-11-22 IL IL165322A patent/IL165322A/en active IP Right Grant
- 2004-11-24 CR CR7598A patent/CR7598A/es not_active Application Discontinuation
- 2004-11-29 ZA ZA200409616A patent/ZA200409616B/xx unknown
- 2004-12-29 NO NO20045700A patent/NO333939B1/no not_active IP Right Cessation
-
2010
- 2010-10-20 JP JP2010235021A patent/JP2011012087A/ja not_active Withdrawn
-
2016
- 2016-08-23 AR ARP160102580A patent/AR105798A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE421317T1 (de) | Pharmazeutische zubereitungen zur oralen anwendung enthaltend pradofloxacin-beladene ionentauscherharze sowie strukturviskose gelbildner als verdicker | |
| ATA1292000A (de) | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen | |
| ATE292960T1 (de) | Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie | |
| EE05149B1 (et) | Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis | |
| AU2002347575A1 (en) | Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same | |
| AU2002257155A1 (en) | Anatomically contoured matrix bands for use in dental restoration procedures | |
| AR028426A1 (es) | Una composicion farmaceutica y procedimiento de tratamiento de enfermedades de disfunsion cognitiva en un mamifero | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| IS7076A (is) | Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni | |
| DE60118859D1 (de) | Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung | |
| DE69941996D1 (de) | Pharmazeutische zusammenstellung zur verwendung in notbehandlungen und dessen herstellungsverfahren | |
| ATA59499A (de) | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung | |
| ATE293978T1 (de) | Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung | |
| DE69903368D1 (de) | Bicyclische aromatische Verbindungen und ihre Anwendung in der Menschen- und Tierheilkunde sowie in der Kosmetikkunde | |
| ITMI20000300A0 (it) | Nebulizzatore medico per liquido da utilizzare nella terapia respiratoria e altre applicazioni | |
| DE60307632D1 (de) | Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung | |
| ATE288766T1 (de) | Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung | |
| ATE383868T1 (de) | Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka | |
| ITMI20010737A0 (it) | Adesivo per protesi dentarie e procedimenti per la sua preparazione | |
| ATE507831T1 (de) | Melatonin enthaltende pharmazeutische formulierung | |
| DE60328119D1 (de) | Pharmazeutische zubereitungen enthaltend modafinil | |
| IL167250A (en) | Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases | |
| AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
| EE200200551A (et) | Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine | |
| ATE418332T1 (de) | Pharmazeutische zusammensetzung enthaltend 5- methyl-2-2'-(chloro-6'- fluoroanilino)phenylessigsäure |